| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-06 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0007 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.19 | 0.002 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.003 |